Dr. Martens rallies on cost-cutting plan and US reboot hopes
Full year profits plunge2025 year of transitionCost savings of £20 million to £25 millionInvestors in Dr. Martens (DOCS) have endured a torrid time since the iconic footwear firm's 2021 IPO (initial public offering), with the shares...
30 May 2024